CYTK – cytokinetics, incorporated (US:NASDAQ)
Stock Stats
News
Cytokinetics (CYTK) Reports Q1 Loss, Lags Revenue Estimates [Yahoo! Finance]
Cytokinetics Reports First Quarter 2024 Financial Results [Yahoo! Finance]
Cytokinetics Reports First Quarter 2024 Financial Results
Cytokinetics, Incorporated (NASDAQ: CYTK) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $94.00 price target on the stock.
Cytokinetics Announces Start of CEDAR-HCM, a Clinical Trial of Aficamten in a Pediatric Population With Symptomatic Obstructive Hypertrophic Cardiomyopathy [Yahoo! Finance]
Form 8-K CYTOKINETICS INC For: May 08
Form 8-K CYTOKINETICS INC For: May 08
Form 8-K CYTOKINETICS INC For: May 08
Form 4 CYTOKINETICS INC For: May 07 Filed by: Malik Fady Ibraham
Form 144 CYTOKINETICS INC Filed by: Malik Fady Ibraham
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.